Chargement en cours...
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can be provided by novel DAAs. Nevertheless, there are still some unmet needs and emerging issues in the treatment of...
Enregistré dans:
| Publié dans: | Clin Mol Hepatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Association for the Study of the Liver
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364348/ https://ncbi.nlm.nih.gov/pubmed/32188235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0018 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|